ArticleNPJ precision oncology2025

G0S2: a potential target for NSCLC identified through prognostic models from multi-Omic analysis of regulatory T cell metabolic genes.

Min Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.